We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Celiac Disease Must Be Evaluated in Patients With Sjögren Syndrome

Xavier Roblin, MD; Frederic Helluwaert, MD; Bruno Bonaz, MD, PhD
Arch Intern Med. 2004;164(21):2386-2387. doi:10.1001/archinte.164.21.2387-b.
Text Size: A A A
Published online


We read with interest the article by Kassan and Moutsopoulos1 about the clinical manifestations of Sjögren syndrome. We are surprised that the authors did not mention celiac disease (CD) as an association. Indeed, Iltanen et al2 found that in a population of 34 patients with primary Sjögren syndrome, 5 patients (14.7%) had CD. This high prevalence has been confirmed by Szodoray et al,3 who observed a CD prevalence of 4.5% in a population of 111 patients with Sjögren syndrome, whereas the prevalence of CD is estimated to be 0.45% in the general population. This is of interest because the authors observed antimitochondrial antibodies in 7% of their patients.1 In those cases, the histopathological appearance is similar to that of early (stage 1) primary biliary cirrhosis. We know that the prevalence of CD in patients with primary biliary cirrhosis is 10-fold higher than that in the general population.4 Consequently, it seems to us that CD must be evaluated in patients with Sjögren syndrome with a screening of antiendomysial (IgA) antibodies as well as immunoglobulin (IgA, IgG, and IgM) dosage, since at least 5% to 10% of patients with CD have an IgA deficiency.5 In these cases, we can test IgG antitransglutaminase antibodies. Screening for CD in such patients is of importance when considering the risk of small bowel adenocarcinomas and lymphomas in patients with CD.6

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles